Search by Drug Name or NDC
NDC 71269-0040-10 Tuxarin 8; 54.3 mg/1; mg/1 Details
Tuxarin 8; 54.3 mg/1; mg/1
Tuxarin is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mainpointe Pharmaceuticals. The primary component is CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE.
MedlinePlus Drug Summary
Chlorpheniramine relieves red, itchy, watery eyes; sneezing; itchy nose or throat; and runny nose caused by allergies, hay fever, and the common cold. Chlorpheniramine helps control the symptoms of cold or allergies but will not treat the cause of the symptoms or speed recovery. Chlorpheniramine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
Related Packages: 71269-0040-10Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Chlorpheniramine
Codeine is used to relieve mild to moderate pain. It is also used, usually in combination with other medications, to reduce coughing. Codeine will help relieve symptoms but will not treat the cause of symptoms or speed recovery. Codeine belongs to a class of medications called opiate (narcotic) analgesics and to a class of medications called antitussives. When codeine is used to treat pain, it works by changing the way the brain and nervous system respond to pain. When codeine is used to reduce coughing, it works by decreasing the activity in the part of the brain that causes coughing. Codeine is also available in combination with acetaminophen (Capital and Codeine, Tylenol with Codeine), aspirin, carisoprodol, and promethazine and as an ingredient in many cough and cold medications. This monograph only includes information about the use of codeine. If you are taking a codeine combination product, be sure to read information about all the ingredients in the product you are taking and ask your doctor or pharmacist for more information.
Related Packages: 71269-0040-10Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Codeine
Product Information
| NDC | 71269-0040 |
|---|---|
| Product ID | 71269-040_e885499e-3423-4377-9f0e-0e315677a7b6 |
| Associated GPIs | 43995202327430 |
| GCN Sequence Number | 074339 |
| GCN Sequence Number Description | chlorpheniramine/codeine phos TAB ER 12H 8MG-54.3MG ORAL |
| HIC3 | B4D |
| HIC3 Description | OPIOID ANTITUSSIVE-1ST GENERATION ANTIHISTAMINE |
| GCN | 38961 |
| HICL Sequence Number | 000347 |
| HICL Sequence Number Description | CHLORPHENIRAMINE MALEATE/CODEINE PHOSPHATE |
| Brand/Generic | Brand |
| Proprietary Name | Tuxarin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | codeine phosphate and chlorpheniramine maleate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 8; 54.3 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | CHLORPHENIRAMINE MALEATE; CODEINE PHOSPHATE |
| Labeler Name | Mainpointe Pharmaceuticals |
| Pharmaceutical Class | Full Opioid Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Opioid Agonist [EPC] |
| DEA Schedule | CIII |
| Marketing Category | NDA |
| Application Number | NDA206323 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 71269-0040-10 (71269004010)
| NDC Package Code | 71269-040-10 |
|---|---|
| Billing NDC | 71269004010 |
| Package | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (71269-040-10) |
| Marketing Start Date | 2018-10-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |